Founders Financial Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Sell
1,751
-8
-0.5% -$8.11K 0.29% 84
2025
Q4
$1.89M Buy
1,759
+5
+0.3% +$4.78K 0.36% 65
2025
Q3
$1.34M Sell
1,754
-125
-7% -$93K 0.25% 93
2025
Q2
$1.46M Sell
1,879
-31
-2% -$24.1K 0.33% 71
2025
Q1
$1.58M Buy
1,910
+333
+21% +$277K 0.38% 57
2024
Q4
$1.22M Sell
1,577
-309
-16% -$256K 0.33% 66
2024
Q3
$1.67M Sell
1,886
-240
-11% -$216K 0.47% 46
2024
Q2
$1.93M Sell
2,126
-1
-0% -$800 0.57% 38
2024
Q1
$1.65M Buy
2,127
+70
+3% +$49.8K 0.5% 43
2023
Q4
$1.2M Sell
2,057
-687
-25% -$401K 0.46% 44
2023
Q3
$1.47M Sell
2,744
-173
-6% -$89.1K 0.64% 32
2023
Q2
$1.37M Buy
2,917
+189
+7% +$79.3K 0.54% 40
2023
Q1
$936K Buy
2,728
+92
+3% +$31K 0.47% 55
2022
Q4
$964K Buy
2,636
+251
+11% +$89K 0.44% 59
2022
Q3
$771K Sell
2,385
-197
-8% -$62.4K 0.39% 67
2022
Q2
$837K Buy
2,582
+192
+8% +$57.6K 0.42% 63
2022
Q1
$685K Buy
2,390
+26
+1% +$6.69K 0.3% 78
2021
Q4
$653K Buy
2,364
+35
+2% +$8.87K 0.26% 87
2021
Q3
$538K Sell
2,329
-60
-3% -$14.8K 0.25% 93
2021
Q2
$551K Buy
2,389
+117
+5% +$23.5K 0.25% 93
2021
Q1
$442K Buy
2,272
+119
+6% +$23.3K 0.22% 105
2020
Q4
$364K Buy
2,153
+63
+3% +$9.41K 0.21% 112
2020
Q3
$306K Buy
+2,090
New +$323K 0.18% 114

Other funds holding LLY

Founders Financial Alliance's LLY Position: Q1 2026 in Review

Founders Financial Alliance reduced its Eli Lilly (LLY) stake by 0.45% in Q1 2026, selling an estimated $8.11K and leaving 1,751 shares worth $1.61M. The position accounts for 0.29% of the portfolio, ranked #84.

Founders Financial Alliance first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.93M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Founders Financial Alliance held 1,751 shares of Eli Lilly worth $1.61M as of Q1 2026.
  • Founders Financial Alliance sold 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
  • Eli Lilly made up 0.29% of Founders Financial Alliance's portfolio in Q1 2026, its #84 holding.
  • Founders Financial Alliance first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
  • Founders Financial Alliance's Eli Lilly position peaked at $1.93M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.